Also trades as: SLXNW (NASDAQ) · $vol 0M
SLXN NASDAQ
Silexion Therapeutics Ltd.
1W: -0.1%
1M: -26.0%
3M: -90.9%
YTD: -86.2%
1Y: -93.1%
$0.26
-0.02 (-6.85%)
Weekly Expected Move ±34.0%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$7M
+152.0% ▲
5Y CAGR: +123.5%
Total Liabilities
$5M
-32.7% ▼
5Y CAGR: +72.8%
Shareholders Equity
$3M
+165.3% ▲
Cash & Investments
$6M
+404.7% ▲
5Y CAGR: +158.7%
Total Debt
$468K
-89.6% ▼
Net Debt
-$6M
-267.2% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $39K | $8M | $5M | $1M | $6M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $39K | $8M | $5M | $1M | $6M |
| Net Receivables | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $0 | $67K | $49K | $97K | $646K |
| Total Current Assets | $408K | $9M | $5M | $2M | $7M |
| Property, Plant & Equip. | $0 | $464K | $247K | $560K | $437K |
| Goodwill & Intangibles | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $115M | $0 | $0 | $0 | $57K |
| Other Non-Current Assets | $0 | $30K | $30K | $53K | $84K |
| Total Non-Current Assets | $115M | $494K | $277K | $613K | $578K |
| Total Assets | $115M | $9M | $5M | $3M | $7M |
| — Liabilities — | |||||
| Accounts Payable | $0 | $240K | $319K | $929K | $787K |
| Short-Term Debt | $0 | $0 | $0 | $1M | $182K |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $349K | $256K | $407K | $644K | $2M |
| Total Current Liabilities | $349K | $2M | $2M | $4M | $3M |
| Long-Term Debt | $0 | $0 | $0 | $3M | $286K |
| Other Non-Current Liab. | $160K | $15M | $15M | $0 | $2M |
| Total Non-Current Liabilities | $160K | $15M | $15M | $3M | $2M |
| Total Liabilities | $509K | $16M | $17M | $7M | $5M |
| — Equity — | |||||
| Common Stock | $115M | $1K | $1K | $2K | $42K |
| Retained Earnings | -$951K | -$22M | -$27M | -$43M | -$55M |
| Accumulated OCI | $0 | $0 | $0 | $0 | $0 |
| Total Stockholders Equity | $115M | -$11M | -$15M | -$4M | $3M |
| Total Liabilities & Equity | $115M | $9M | $5M | $3M | $7M |
| — Key Metrics — | |||||
| Total Debt | $0 | $271K | $171K | $4M | $468K |
| Net Debt | -$39K | -$8M | -$4M | $3M | -$6M |
| Total Investments | $115M | $0 | $0 | $0 | $57K |